Back
NYLI MacKay Muni Intermediate ETF Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Buy
64
MMIT
NYLI MacKay Muni Intermediate ETF
Last Price:
$24.31
Seasonality Move:
-1.46%
Sell
43
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$397.25
Seasonality Move:
0.84%
Buy
64
NYLI MacKay Muni Intermediate ETF (MMIT)
is a Buy
Is NYLI MacKay Muni Intermediate ETF a Buy, Sell or Hold?
-
The current NYLI MacKay Muni Intermediate ETF [MMIT] share price is $24.39. The Score for MMIT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
MMIT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $398.82. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MMIT Stock Price Chart
What is NYLI MacKay Muni Intermediate ETF's stock price today?
-
The NYLI MacKay Muni Intermediate ETF share price today is $24.39The current trend is moderately bearish and MMIT is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $398.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
MMIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 58.29 | Buy |
| Chaikin Money Flow: | -94604 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.3 - 24.38) | Buy |
| Bollinger Bands (100): | (24.02 - 24.42) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -13.02 | Sell |
| Relative Strength Index (14 RSI): | 38.18 | Sell |
| Chaikin Money Flow: | -239813 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (395.38 - 448.66) | Sell |
| Bollinger Bands (100): | (424.51 - 470.03) | Sell |
MMIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.37 | Buy |
| 20-day SMA: | 24.34 | Buy |
| 50-day SMA: | 24.36 | Buy |
| 200-day SMA: | 24 | Buy |
| 8-day EMA: | 24.37 | Buy |
| 20-day EMA: | 24.35 | Buy |
| 50-day EMA: | 23.97 | Buy |
| 200-day EMA: | 15.76 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 399.36 | Sell |
| 20-day SMA: | 417.68 | Sell |
| 50-day SMA: | 439.71 | Sell |
| 200-day SMA: | 369.63 | Buy |
| 8-day EMA: | 401.33 | Sell |
| 20-day EMA: | 412.78 | Sell |
| 50-day EMA: | 428.62 | Sell |
| 200-day EMA: | 383.63 | Buy |
NYLI MacKay Muni Intermediate ETF Earnings Growth & MMIT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.23 per share, and a decrease next year of $0.00 per share.
NYLI MacKay Muni Intermediate ETF Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||